Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. (2017)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.27159
PubMed Identifier: 28826504
Publication URI: http://europepmc.org/abstract/MED/28826504
Type: Journal Article/Review
Volume: 6
Parent Publication: eLife
ISSN: 2050-084X